K08670903

Kromasil^® Eternity^™ C18 HPLC Column

5 μm particle size, pore size 100 Å, L × I.D. 250 mm × 4.6 mm

• Sinonimo/i: Kromasil C18
• Codice UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Proprietà

• agenzia: suitable for USP L1
• Nome Commerciale: Kromasil^®
• Produttore/marchio commerciale: Kromasil^® ET-5-C18-4.6X250
• Disponibilità: available only in USA, Canada and Puerto Rico
• Grado di funzionalizzazione: 14% Carbon loading
• tecniche: HPLC: suitable
• Lungh. × D.I.: 250 mm × 4.6 mm
• Area superficiale: 330 m²/g
• Gruppo funzionale matrice: C18 (octadecyl) phase
• Dimensione particelle: 5 μm
• Dimensione pori: 100 Å
• Intervallo di pH: 1-12
• applicazioni: food and beverages
• Tecnica di separazione: reversed phase

Descrizione

Applicazioni

• Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.: This study developed and validated an HPLC-MS/MS method for determining clopidogrel in human plasma. The Kromasil^® Eternity C18 HPLC column was employed to achieve the separation. This method was shown to be efficient, precise, and suitable for pharmacokinetic studies (Liu et al., 2016).


• Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.: The study focused on developing a stability-indicating assay method for atorvastatin and ezetimibe using UPLC. The Kromasil^® Eternity C18 HPLC column was critical in achieving the required resolution and sensitivity, demonstrating its role in stability studies of pharmaceutical combinations (Goel et al., 2013).

Note legali

Eternity is a trademark of EKA Chemicals AB

Kromasil is a registered trademark of EKA Chemicals AB